Deficiency vitamin D in nanoscale and its incidence on obesity
DOI:
https://doi.org/10.56053/10.S.439Keywords:
Vitamin D3 deficiency, Obesity, Body mass index, nano scaleAbstract
Being overweight is referred to as obesity, which is a global health concern. The well-established finding that vitamin D (VD) insufficiency is more prevalent in nano scale on obese individuals is most likely the result of volumetric dilution into higher volumes of muscle, liver, serum, and fat; however, other routes may also be at play and cannot be completely ruled out. Hence, this study aimed to investigate the role of vitamin D3 in nano scale for occurrence of obesity among Iraqi patients. This study was included 100 patients suffering from obesity with age ranged from 8 to 70 years and weight ranged from 20 to 95 kg. Among 100 patients diagnosed with obesity, the results in Figure 1 indicated that 34% of patients were diagnosed with deficiency (<10 ng/ml) and insufficiency (10-30 ng/ml) of vitamin D3, while 32% of these patients were not suffering from deficiency of this vitamin (30 – 100 ng/ml). The majority of patients were included in 70-79 kg age group by 53%.
Downloads
References
-[1] O. Lisakovska, I. Shymanskyi, D. Labudzynskyi, A. Mazanova, M. Veliky, Int. J. Endocrinol. 2020 (2020) https://doi.org/10.1155/2020/5471512
-[2] L. Vranić, I. Mikolašević, S. Milić, Medicina (B Aires) 55 (2019) 541 https://doi.org/10.3390/medicina55100541
-[3] M.S. Cattaruzza, Eur. J. Cancer Prev. 28 (2019) 203 https://doi.org/10.1097/CEJ.0000000000000457
-[4] S. Milic, Drug Des. Dev. Ther. 9 (2015) 4835 https://doi.org/10.2147/DDDT.S87936
-[5] F.A. Fakhry, Iraqi J. Sci. (2017) 2041
-[6] M.N.J. Al-Darrji, A.F. Shehab, N.Y. Yaseen, R.M. Karim, Iraqi J. Sci. (2015) 1639
-[7] SAS, Statistical Analysis System, User’s Guide, Version 9.6, 6th ed., SAS Inst. Inc., Cary, N.C., USA, 2018
-[8] S. Wieder-Huszla, Int. J. Environ. Res. Public Health 16 (2019) 175 https://doi.org/10.3390/ijerph16010175
-[9] N. Sahu, A. Kumar, U. Yezdani, Arch. Nutr. Public Health 2 (2020) 1
-[10] I. Zakharova, Front. Endocrinol. (Lausanne) 10 (2019) 103 https://doi.org/10.3389/fendo.2019.00103
-[11] G. Ghigliotti, Inflammation 37 (2014) 1337 https://doi.org/10.1007/s10753-014-9840-9
-[12] M.A. Abbas, J. Steroid Biochem. Mol. Biol. 165 (2017) 369 https://doi.org/10.1016/j.jsbmb.2016.06.015
-[13] P. Manna, S.K. Jain, Metab. Syndr. Relat. Disord. 13 (2015) 423 https://doi.org/10.1089/met.2015.0052
-[14] S. Sokary, H. Almaghrbi, H. Bawadi, Diabetes Metab. Syndr. Obes. (2024) 925
-[15] A.O. Agbaje, Pediatr. Res. (2024) 1
-[16] M.J. Concepción-Zavaleta, World J. Pediatr. 20 (2024) 26 https://doi.org/10.1007/s12519-023-00725-5
-[17] J.R. Speakman, K.D. Hall, Philos. Trans. R. Soc. B 378 (2023) 20220231 https://doi.org/10.1098/rstb.2022.0231
-[18] A. Bar, O. Karin, A. Mayo, D. Ben-Zvi, U. Alon, iScience 26 (2023) https://doi.org/10.1016/j.isci.2023.106653
-[19] S. Onagbiye, H. Ricci, P. Bester, C. Ricci, J. Public Health Africa 14 (2023) 4 https://doi.org/10.4081/jphia.2023.2472
-[20] Haneen Khaled Naji Al-Samarrai, Osama Nadhom Nijris, Mohammed Fadhil AboKsou, Exp. Theo. NANOTECHNOLOGY 9 (2025) 529 https://doi.org/10.56053/9.4.529
-[21] M. Sadeldine, Exp. Theo. NANOTECHNOLOGY 9 (2025) 1 https://doi.org/10.56053/9.1.1
-[22] N. M. Slaber, J. S. Kith, Exp. Theo. NANOTECHNOLOGY 9 (2025) 9 https://doi.org/10.56053/9.1.9
-[23] Badis Bendjemil, Maram Mechi, Khaoula Safi, Mounir Ferhi, Karima Horchani Naifer, Exp. Theo. NANOTECHNOLOGY 8(2024) 51 https://doi.org/10.56053/8.3.51